ET
Healthcare & Life Sciences
Eidos Therapeutics
United States
Eidos Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
series-b
series-b
Stage
1
Investors
About Eidos Therapeutics
Based in the United States, Eidos Therapeutics is a startup. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Eidos Therapeutics is a biopharmaceutical company developing precision medicines for genetically defined, debilitating transthyretin amyloidosis.
Explore Eidos Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.